Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
63 participants
OBSERVATIONAL
2018-04-01
2020-04-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Tacrolimus
Patients were treated with 0.03 % tacrolimus ointment twice daily for 6 months.
Tacrolimus ointment
Patients were treated with 0.03 % tacrolimus ointment twice daily for 6 months.
Phototherapeutic Keratectomy
Patients underwent transepithelial PTK for subepithelial infiltrates.
phototherapeutic keratectomy
Patients underwent transepithelial PTK for subepithelial infiltrates.
Control
patients received only artificial tears eyedrop
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tacrolimus ointment
Patients were treated with 0.03 % tacrolimus ointment twice daily for 6 months.
phototherapeutic keratectomy
Patients underwent transepithelial PTK for subepithelial infiltrates.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Benha University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tarek Roshdy mohamed Mahgoub ELhamaky
Lecturer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
TAREK R ELHAMAKY
Role: PRINCIPAL_INVESTIGATOR
Benha university faculty of medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
INMC
Abu Dhabi, , United Arab Emirates
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Elhamaky TR. Pentacam corneal densitometry-guided treatment of adenoviral corneal subepithelial infiltrates: a comparative study between transepithelial phototherapeutic keratectomy and topical tacrolimus. Int Ophthalmol. 2021 Jan;41(1):67-77. doi: 10.1007/s10792-020-01553-8. Epub 2020 Aug 27.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Hamaky5
Identifier Type: -
Identifier Source: org_study_id